C-peptide: difference between revisions
Diff·revision 3 → 4·20:05, 20 Sep 2024
Difference between revision 3 and revision 4 of C-peptide. 2 lines changed; the page grew by 280 bytes.
| Revision 3 — 16:32, 9 Sep 2024 ArchiveBot (talk) bot: normalise unit spacing 1,892 bytes ±0 | Revision 4 — 20:05, 20 Sep 2024 DEXA_Dilys (talk) alphabetise the see-also list 2,172 bytes +280 | ||
|---|---|---|---|
| 16 | Simpler indices are used clinically. A fasting C-peptide with a simultaneous glucose distinguishes states of insulin deficiency from insulin resistance; a stimulated C-peptide after a mixed meal or glucagon assesses residual secretory capacity. | 16 | Simpler indices are used clinically. A fasting C-peptide with a simultaneous glucose distinguishes states of insulin deficiency from insulin resistance; a stimulated C-peptide after a mixed meal or glucagon assesses residual secretory capacity. |
| 17 | 17 | ||
| + | 18 | The most common clinical use is classification: a very low C-peptide with hyperglycaemia indicates insulin deficiency, while a normal or high value with hyperglycaemia indicates resistance with preserved secretion. The thresholds are assay- and context-dependent.{{r|jones2013}} | |
| + | 19 | ||
| 18 | == References == | 20 | == References == |
| 19 | {{reflist}} | 21 | {{reflist}} |